Skip to content

Constructive Self Assertiveness Via the Internet

Constructive Self Assertiveness Via the Internet

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04240249
Acronym
R2
Enrollment
210
Registered
2020-01-27
Start date
2020-02-01
Completion date
2022-12-31
Last updated
2024-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Problems With Self-assertiveness

Brief summary

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated. In a randomized controlled trial three groups will be compared: 1. constructive self-assertiveness with guidance 2. constructive self-assertiveness without guidance 3. Waitlist control

Detailed description

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated. In a randomized controlled trial three groups will be compared: 1. constructive self-assertiveness with guidance 2. constructive self-assertiveness without guidance 3. Waitlist control The treatment (and wait) will be 10 weeks.

Interventions

BEHAVIORALConstructive self-assertiveness program via the internet

Participants will get one chapter a week to work with. All chapters are presented on web pages and include information and exercises and end with homework assignments.

Sponsors

Stockholm University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

A randomized controlled trial with three groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Human, * At least 18 years old, * Able to speak and read Swedish, * Informed consent.

Exclusion criteria

* Severe depression (as defined by a PHQ9 score of 15 points or higher), * If on medication the dosage has been stable for at least the past 3 months, * No ongoing psychotherapy.

Design outcomes

Primary

MeasureTime frameDescription
Adaptive and Aggressive Assertiveness ScaleUp to 12 monthsA self-report questionnaire measuring Adaptive and Aggressive Assertiveness. Higher scores mean a worse outcome. Minimum and maximum values: 30-150.

Secondary

MeasureTime frameDescription
Patient Health Questionnaire 9-itemUp to 12 monthsDepression questionnaire. Higher scores mean a worse outcome. Higher scores mean a worse outcome. Minimum and maximum values: 0-27.
Generalized Anxiety Disorder 7Up to 12 monthsGeneral Anxiety questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: 0-27.
Liebowitz Social Anxiety Scale , self-reportUp to 12 monthsSocial Anxiety questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: 0-144.
Rathus Assertiveness ScheduleUp to 12 monthsAssertiveness questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: -30 to +30.
Well-being scaleUp to 12 monthsDepression scale. Lower scores mean a worse outcome. Minimum and maximum values: 0-72.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026